Clinical trials
Phase 1/2 Small Cell Lung Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
| Unknown status | 7 |
| Not yet recruiting | 4 |
| Completed | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 3 |
| Anhui Provincial Hospital | 2 |
| Beijing Biotech | 2 |
| Boehringer Ingelheim | 2 |
| Advenchen Laboratories Nanjing Ltd. | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| Baohui Han | 1 |
| BioNTech SE | 1 |
| Biocity Biopharmaceutics Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 38 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Neuroendocrine | 3 |
| Prostatic Neoplasms | 3 |
| Recurrence | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Uterine Cervical Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Breast Neoplasms | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.